🔎 Trials Near Me

Home › Kanser sa Baga › Pennsylvania

Pag-aaral pangklinika para sa Kanser sa Baga sa Pennsylvania

57 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Alliance Cancer Specialists, Sellersville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06765109

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • at 53 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Bryn Mawr Hospital, Bryn Mawr
  • Penn State Milton S Hershey Medical Center, Hershey
  • Riddle Memorial Hospital, Media
  • at 6 pa
Nagre-recruitPhase 3
Edad 70 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Bryn Mawr Hospital, Bryn Mawr
  • at 12 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT04181060

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Penn State Milton S. Hershey Medical Center, Hershey
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06881784

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Bryn Mawr Hospital, Bryn Mawr
  • at 14 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06498635

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Alliance Cancer Specialists - Media, Media
  • Guthrie Medical Group, Sayre
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05920356

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
  • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312137

A Registry for People With Lung Cancer

  • Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
  • ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Pittsburgh
Nagre-recruitPhase 2
Edad 18 hanggang 95 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • Hospital of the University of Pennsylvania, Philadelphia
  • West Penn Allegheny Health, Pittsburgh
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06287775

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
  • WellSpan York Cancer Center, York
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04585750

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • St. Luke's University Health Network, Bethlehem
  • Allegheny Cancer Center, Pittsburgh
  • Reading Hospital - McGlinn Cancer Institute, West Reading
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Alliance Cancer Specialists, PC, Horsham
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07012031

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Philadelphia
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • at 7 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06712355

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  • Hospital of the University of Pennsylvania, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07499674

Pemefolacianine for IMI of Lung Cancer

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07772895

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

  • Abramson Cancer Center ( Site 0010), Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06731907

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Chambersburg Hospital, Chambersburg
  • Geisinger Medical Center, Danville
  • at 17 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05624996

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • IRMC Cancer Center, Indiana
  • UPMC Hillman Cancer Center - New Castle, New Castle
  • at 2 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07059884

Empathic Communication Skills (ECS) Training

  • University of Pennsylvania (Data Collection Only), Philadelphia
  • Fox Chase Cancer Center (Data Collection Only), Philadelphia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT05456841

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

  • Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06060613

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07315113

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06162221

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Sidney Kimmel Cancer Center, Philadelphia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Allegheny General Hospital, Natrona Heights
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT04614103

MOv19-BBz CAR T Cells in FRa+ Cancers

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07116057

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • at 37 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

  • Penn Medicine University City, Philadelphia
  • Perelman Center for Advanced Medicine, Philadelphia
  • Penn Medicine Washington Square, Philadelphia
Nagre-recruit
Edad 35 hanggang 89 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT05968898

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 hanggang 77 · Lahat ng kasarian · Na-update May 29, 2026 · NCT05679349

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 28, 2026 · NCT07102147

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

  • Fox Chase Cancer Center, Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05800587

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.